These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D, Sangiorgi F, Snead ML, Maxson RE. Dev Biol; 1999 Jan 15; 205(2):260-74. PubMed ID: 9917362 [Abstract] [Full Text] [Related]
4. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures. Ignelzi MA, Wang W, Young AT. J Bone Miner Res; 2003 Apr 15; 18(4):751-9. PubMed ID: 12674336 [Abstract] [Full Text] [Related]
5. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T, Takano Y, Uchiyama M, Heaney S, Peters H, Tang Z, Maxson R, Maas R. Nat Genet; 2000 Apr 15; 24(4):391-5. PubMed ID: 10742104 [Abstract] [Full Text] [Related]
8. Progression of calvarial bone development requires Foxc1 regulation of Msx2 and Alx4. Rice R, Rice DP, Olsen BR, Thesleff I. Dev Biol; 2003 Oct 01; 262(1):75-87. PubMed ID: 14512019 [Abstract] [Full Text] [Related]